SAM
ZYME icon

Silvercrest Asset Management’s Zymeworks ZYME Stock Holding History

Silvercrest Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.1M Sell
163,649
-18,141
-10% -$429K 0.03% 451
2025
Q4 		$4.79M Sell
181,790
-91,007
-33% -$1.99M 0.03% 438
2025
Q3 		$4.66M Sell
272,797
-7,929
-3% -$113K 0.03% 435
2025
Q2 		$3.52M Hold
280,726
– – 0.02% 473
2025
Q1 		$3.34M Sell
280,726
-1,619
-0.6% -$22.1K 0.02% 467
2024
Q4 		$4.13M Sell
282,345
-2,770
-1% -$38.7K 0.03% 448
2024
Q3 		$3.58M Sell
285,115
-113,029
-28% -$1.23M 0.02% 421
2024
Q2 		$3.39M Buy
398,144
+5,123
+1% +$45.6K 0.02% 449
2024
Q1 		$4.13M Buy
393,021
+17,173
+5% +$191K 0.03% 421
2023
Q4 		$3.91M Hold
375,848
– – 0.03% 413
2023
Q3 		$2.38M Sell
375,848
-950
-0.3% -$7.02K 0.02% 461
2023
Q2 		$3.26M Buy
+376,798
New +$3.37M 0.02% 428
2022
Q2 		– Sell
-222,627
Closed -$1.46M – 861
2022
Q1 		$1.46M Buy
222,627
+2,092
+0.9% +$18.6K 0.01% 545
2021
Q4 		$3.62M Buy
220,535
+114,709
+108% +$2.39M 0.02% 418
2021
Q3 		$3.07M Sell
105,826
-2,427
-2% -$80.7K 0.02% 443
2021
Q2 		$3.75M Sell
108,253
-316
-0.3% -$10K 0.02% 428
2021
Q1 		$3.43M Buy
108,569
+26,651
+33% +$1.08M 0.02% 429
2020
Q4 		$3.87M Buy
+81,918
New +$3.8M 0.03% 394

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Silvercrest Asset Management's ZYME Position: Q1 2026 in Review

Silvercrest Asset Management reduced its Zymeworks (ZYME) stake by 10% in Q1 2026, selling an estimated $429K and leaving 163,649 shares worth $4.1M. The position accounts for 0.03% of the portfolio, ranked #451.

Silvercrest Asset Management first reported a position in ZYME in Q4 2020 and has held it in 18 quarters since. The position peaked at $4.79M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Silvercrest Asset Management held 163,649 shares of Zymeworks worth $4.1M as of Q1 2026.
  • Silvercrest Asset Management sold 18,141 Zymeworks shares in Q1 2026, an estimated $429K.
  • Zymeworks made up 0.03% of Silvercrest Asset Management's portfolio in Q1 2026, its #451 holding.
  • Silvercrest Asset Management first reported a position in Zymeworks in Q4 2020 and has held it in 18 quarters since.
  • Silvercrest Asset Management's Zymeworks position peaked at $4.79M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.